nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CXCL8—psoriasis	0.223	1	CbGaD
Diclofenac—migraine—Prednisone—psoriasis	0.142	0.508	CpDpCtD
Diclofenac—osteoarthritis—Prednisone—psoriasis	0.137	0.492	CpDpCtD
Diclofenac—UGT2B7—Mycophenolic acid—psoriasis	0.0281	0.0871	CbGbCtD
Diclofenac—UGT1A1—Mycophenolic acid—psoriasis	0.0243	0.0753	CbGbCtD
Diclofenac—CYP1A1—Clobetasol propionate—psoriasis	0.0229	0.0708	CbGbCtD
Diclofenac—UGT2B7—Mycophenolate mofetil—psoriasis	0.0157	0.0487	CbGbCtD
Diclofenac—UGT1A1—Mycophenolate mofetil—psoriasis	0.0136	0.0421	CbGbCtD
Diclofenac—CYP1A1—Methoxsalen—psoriasis	0.012	0.0372	CbGbCtD
Diclofenac—SLCO1C1—Methotrexate—psoriasis	0.0116	0.0359	CbGbCtD
Diclofenac—ALB—Acitretin—psoriasis	0.011	0.0341	CbGbCtD
Diclofenac—CYP2C8—Tazarotene—psoriasis	0.0108	0.0333	CbGbCtD
Diclofenac—CYP1A2—Clobetasol propionate—psoriasis	0.0102	0.0316	CbGbCtD
Diclofenac—ABCC1—Cyclosporine—psoriasis	0.00846	0.0262	CbGbCtD
Diclofenac—PTGS2—Triamcinolone—psoriasis	0.00817	0.0253	CbGbCtD
Diclofenac—CYP1A1—Cholecalciferol—psoriasis	0.00796	0.0246	CbGbCtD
Diclofenac—PTGS2—Betamethasone—psoriasis	0.00701	0.0217	CbGbCtD
Diclofenac—CYP2B6—Cholecalciferol—psoriasis	0.00606	0.0188	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—psoriasis	0.00599	0.0185	CbGbCtD
Diclofenac—ABCC4—Methotrexate—psoriasis	0.00557	0.0173	CbGbCtD
Diclofenac—CYP1A2—Methoxsalen—psoriasis	0.00536	0.0166	CbGbCtD
Diclofenac—PLA2G2A—synovial fluid—psoriasis	0.0052	0.423	CbGeAlD
Diclofenac—ALB—Mycophenolate mofetil—psoriasis	0.00515	0.0159	CbGbCtD
Diclofenac—CYP2C8—Cholecalciferol—psoriasis	0.00459	0.0142	CbGbCtD
Diclofenac—SLC22A6—Cyclosporine—psoriasis	0.00458	0.0142	CbGbCtD
Diclofenac—ABCC1—Methotrexate—psoriasis	0.00448	0.0139	CbGbCtD
Diclofenac—ALB—Prednisone—psoriasis	0.00412	0.0127	CbGbCtD
Diclofenac—PTGS2—Dexamethasone—psoriasis	0.00408	0.0126	CbGbCtD
Diclofenac—CYP2C8—Mycophenolate mofetil—psoriasis	0.00398	0.0123	CbGbCtD
Diclofenac—CYP2C19—Cholecalciferol—psoriasis	0.00385	0.0119	CbGbCtD
Diclofenac—CYP3A4—Calcitriol—psoriasis	0.00361	0.0112	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—psoriasis	0.00348	0.0108	CbGbCtD
Diclofenac—CYP1A1—Dexamethasone—psoriasis	0.00344	0.0107	CbGbCtD
Diclofenac—CYP2C9—Cholecalciferol—psoriasis	0.0032	0.00991	CbGbCtD
Diclofenac—CYP2C8—Hydrocortisone—psoriasis	0.00319	0.00989	CbGbCtD
Diclofenac—CYP2C8—Cyclosporine—psoriasis	0.00302	0.00934	CbGbCtD
Diclofenac—CYP3A4—Methoxsalen—psoriasis	0.00281	0.0087	CbGbCtD
Diclofenac—ABCB1—Mycophenolate mofetil—psoriasis	0.00269	0.00834	CbGbCtD
Diclofenac—CYP2C19—Prednisone—psoriasis	0.00267	0.00826	CbGbCtD
Diclofenac—CYP2E1—Dexamethasone—psoriasis	0.00266	0.00823	CbGbCtD
Diclofenac—CYP2B6—Dexamethasone—psoriasis	0.00262	0.00812	CbGbCtD
Diclofenac—CYP2C19—Cyclosporine—psoriasis	0.00253	0.00783	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—psoriasis	0.00243	0.00751	CbGbCtD
Diclofenac—ABCB1—Betamethasone—psoriasis	0.00231	0.00716	CbGbCtD
Diclofenac—ABCB1—Prednisolone—psoriasis	0.00228	0.00706	CbGbCtD
Diclofenac—ABCB1—Hydrocortisone—psoriasis	0.00216	0.00669	CbGbCtD
Diclofenac—ABCB1—Prednisone—psoriasis	0.00215	0.00667	CbGbCtD
Diclofenac—CYP2C9—Cyclosporine—psoriasis	0.0021	0.00651	CbGbCtD
Diclofenac—ALB—Methotrexate—psoriasis	0.00207	0.00639	CbGbCtD
Diclofenac—ABCB1—Cyclosporine—psoriasis	0.00204	0.00632	CbGbCtD
Diclofenac—TTR—vertebral column—psoriasis	0.00202	0.164	CbGeAlD
Diclofenac—CYP2C8—Dexamethasone—psoriasis	0.00199	0.00615	CbGbCtD
Diclofenac—CYP3A4—Cholecalciferol—psoriasis	0.00186	0.00576	CbGbCtD
Diclofenac—CYP2C19—Dexamethasone—psoriasis	0.00167	0.00516	CbGbCtD
Diclofenac—CYP3A4—Triamcinolone—psoriasis	0.00161	0.005	CbGbCtD
Diclofenac—CYP3A4—Mycophenolate mofetil—psoriasis	0.00161	0.005	CbGbCtD
Diclofenac—CYP2C9—Dexamethasone—psoriasis	0.00139	0.00429	CbGbCtD
Diclofenac—CYP3A4—Betamethasone—psoriasis	0.00139	0.00429	CbGbCtD
Diclofenac—CYP3A4—Prednisolone—psoriasis	0.00137	0.00423	CbGbCtD
Diclofenac—ABCB1—Dexamethasone—psoriasis	0.00134	0.00416	CbGbCtD
Diclofenac—CYP3A4—Hydrocortisone—psoriasis	0.0013	0.00401	CbGbCtD
Diclofenac—CYP3A4—Prednisone—psoriasis	0.00129	0.00399	CbGbCtD
Diclofenac—CYP3A4—Cyclosporine—psoriasis	0.00122	0.00379	CbGbCtD
Diclofenac—ABCB1—Methotrexate—psoriasis	0.00108	0.00335	CbGbCtD
Diclofenac—PTGS2—skeletal joint—psoriasis	0.000884	0.0719	CbGeAlD
Diclofenac—CYP3A4—Dexamethasone—psoriasis	0.000806	0.00249	CbGbCtD
Diclofenac—PTGS2—synovial membrane of synovial joint—psoriasis	0.000671	0.0546	CbGeAlD
Diclofenac—CYP1A1—skin epidermis—psoriasis	0.000513	0.0417	CbGeAlD
Diclofenac—PTGS2—skin epidermis—psoriasis	0.000431	0.035	CbGeAlD
Diclofenac—PLA2G2A—tendon—psoriasis	0.000387	0.0315	CbGeAlD
Diclofenac—PTGS1—endothelium—psoriasis	0.000327	0.0266	CbGeAlD
Diclofenac—PTGS2—endothelium—psoriasis	0.000312	0.0254	CbGeAlD
Diclofenac—SCN4A—tendon—psoriasis	0.0003	0.0244	CbGeAlD
Diclofenac—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000262	0.157	CbGdCrCtD
Diclofenac—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000209	0.126	CbGdCrCtD
Diclofenac—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000204	0.122	CbGdCrCtD
Diclofenac—ABCC4—tendon—psoriasis	0.00018	0.0147	CbGeAlD
Diclofenac—CYP1A1—skin of body—psoriasis	0.000159	0.0129	CbGeAlD
Diclofenac—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000158	0.0949	CbGdCrCtD
Diclofenac—CYP2B6—skin of body—psoriasis	0.000154	0.0126	CbGeAlD
Diclofenac—ABCC1—tendon—psoriasis	0.000154	0.0125	CbGeAlD
Diclofenac—PTGS1—skin of body—psoriasis	0.00014	0.0114	CbGeAlD
Diclofenac—PTGS2—skin of body—psoriasis	0.000133	0.0109	CbGeAlD
Diclofenac—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000126	0.076	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000126	0.076	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000123	0.0738	CbGdCrCtD
Diclofenac—CYP2E1—tendon—psoriasis	0.00011	0.00898	CbGeAlD
Diclofenac—PTGS1—tendon—psoriasis	0.000106	0.00865	CbGeAlD
Diclofenac—PTGS2—tendon—psoriasis	0.000102	0.00827	CbGeAlD
Diclofenac—PTGS2—Fluocinonide—Betamethasone—psoriasis	9.55e-05	0.0574	CbGdCrCtD
Diclofenac—PTGS2—Fluocinonide—Dexamethasone—psoriasis	9.55e-05	0.0574	CbGdCrCtD
Diclofenac—PTGS2—Fluocinonide—Triamcinolone—psoriasis	9.33e-05	0.0561	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	5.76e-05	0.0346	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	5.76e-05	0.0346	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	5.63e-05	0.0338	CbGdCrCtD
Diclofenac—Pain—Prednisolone—psoriasis	1.73e-05	0.00014	CcSEcCtD
Diclofenac—Haemorrhage—Methotrexate—psoriasis	1.73e-05	0.00014	CcSEcCtD
Diclofenac—Hepatitis—Methotrexate—psoriasis	1.73e-05	0.00014	CcSEcCtD
Diclofenac—Urticaria—Mycophenolate mofetil—psoriasis	1.73e-05	0.00014	CcSEcCtD
Diclofenac—Headache—Mycophenolic acid—psoriasis	1.73e-05	0.00014	CcSEcCtD
Diclofenac—Decreased appetite—Hydrocortisone—psoriasis	1.72e-05	0.000139	CcSEcCtD
Diclofenac—Pharyngitis—Methotrexate—psoriasis	1.72e-05	0.000139	CcSEcCtD
Diclofenac—Abdominal pain—Mycophenolate mofetil—psoriasis	1.72e-05	0.000139	CcSEcCtD
Diclofenac—Body temperature increased—Mycophenolate mofetil—psoriasis	1.72e-05	0.000139	CcSEcCtD
Diclofenac—Urinary tract disorder—Methotrexate—psoriasis	1.71e-05	0.000138	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Hydrocortisone—psoriasis	1.71e-05	0.000138	CcSEcCtD
Diclofenac—Fatigue—Hydrocortisone—psoriasis	1.71e-05	0.000138	CcSEcCtD
Diclofenac—Vision blurred—Prednisone—psoriasis	1.7e-05	0.000138	CcSEcCtD
Diclofenac—Urethral disorder—Methotrexate—psoriasis	1.7e-05	0.000137	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Triamcinolone—psoriasis	1.7e-05	0.000137	CcSEcCtD
Diclofenac—Pain—Hydrocortisone—psoriasis	1.69e-05	0.000137	CcSEcCtD
Diclofenac—Oedema—Betamethasone—psoriasis	1.69e-05	0.000137	CcSEcCtD
Diclofenac—Anaphylactic shock—Dexamethasone—psoriasis	1.69e-05	0.000137	CcSEcCtD
Diclofenac—Oedema—Dexamethasone—psoriasis	1.69e-05	0.000137	CcSEcCtD
Diclofenac—Anaphylactic shock—Betamethasone—psoriasis	1.69e-05	0.000137	CcSEcCtD
Diclofenac—Insomnia—Triamcinolone—psoriasis	1.69e-05	0.000136	CcSEcCtD
Diclofenac—Infection—Dexamethasone—psoriasis	1.68e-05	0.000136	CcSEcCtD
Diclofenac—Infection—Betamethasone—psoriasis	1.68e-05	0.000136	CcSEcCtD
Diclofenac—Ill-defined disorder—Prednisone—psoriasis	1.67e-05	0.000135	CcSEcCtD
Diclofenac—Paraesthesia—Triamcinolone—psoriasis	1.67e-05	0.000135	CcSEcCtD
Diclofenac—Feeling abnormal—Prednisolone—psoriasis	1.67e-05	0.000135	CcSEcCtD
Diclofenac—Visual impairment—Methotrexate—psoriasis	1.67e-05	0.000135	CcSEcCtD
Diclofenac—Anaemia—Prednisone—psoriasis	1.67e-05	0.000135	CcSEcCtD
Diclofenac—Shock—Dexamethasone—psoriasis	1.66e-05	0.000135	CcSEcCtD
Diclofenac—Shock—Betamethasone—psoriasis	1.66e-05	0.000135	CcSEcCtD
Diclofenac—Dyspnoea—Triamcinolone—psoriasis	1.66e-05	0.000134	CcSEcCtD
Diclofenac—Nervous system disorder—Dexamethasone—psoriasis	1.66e-05	0.000134	CcSEcCtD
Diclofenac—Nervous system disorder—Betamethasone—psoriasis	1.66e-05	0.000134	CcSEcCtD
Diclofenac—Agitation—Prednisone—psoriasis	1.66e-05	0.000134	CcSEcCtD
Diclofenac—Thrombocytopenia—Dexamethasone—psoriasis	1.66e-05	0.000134	CcSEcCtD
Diclofenac—Thrombocytopenia—Betamethasone—psoriasis	1.66e-05	0.000134	CcSEcCtD
Diclofenac—Tachycardia—Betamethasone—psoriasis	1.65e-05	0.000134	CcSEcCtD
Diclofenac—Tachycardia—Dexamethasone—psoriasis	1.65e-05	0.000134	CcSEcCtD
Diclofenac—Angioedema—Prednisone—psoriasis	1.65e-05	0.000133	CcSEcCtD
Diclofenac—Hypersensitivity—Cyclosporine—psoriasis	1.64e-05	0.000133	CcSEcCtD
Diclofenac—Dyspepsia—Triamcinolone—psoriasis	1.64e-05	0.000133	CcSEcCtD
Diclofenac—Erythema multiforme—Methotrexate—psoriasis	1.64e-05	0.000132	CcSEcCtD
Diclofenac—Nausea—Mycophenolic acid—psoriasis	1.64e-05	0.000132	CcSEcCtD
Diclofenac—Hyperhidrosis—Betamethasone—psoriasis	1.64e-05	0.000132	CcSEcCtD
Diclofenac—Hyperhidrosis—Dexamethasone—psoriasis	1.64e-05	0.000132	CcSEcCtD
Diclofenac—Feeling abnormal—Hydrocortisone—psoriasis	1.63e-05	0.000132	CcSEcCtD
Diclofenac—Malaise—Prednisone—psoriasis	1.63e-05	0.000132	CcSEcCtD
Diclofenac—Vertigo—Prednisone—psoriasis	1.62e-05	0.000131	CcSEcCtD
Diclofenac—Eye disorder—Methotrexate—psoriasis	1.62e-05	0.000131	CcSEcCtD
Diclofenac—Gastrointestinal pain—Hydrocortisone—psoriasis	1.62e-05	0.000131	CcSEcCtD
Diclofenac—Syncope—Prednisone—psoriasis	1.62e-05	0.000131	CcSEcCtD
Diclofenac—Tinnitus—Methotrexate—psoriasis	1.62e-05	0.000131	CcSEcCtD
Diclofenac—Anorexia—Dexamethasone—psoriasis	1.61e-05	0.00013	CcSEcCtD
Diclofenac—Anorexia—Betamethasone—psoriasis	1.61e-05	0.00013	CcSEcCtD
Diclofenac—Urticaria—Prednisolone—psoriasis	1.61e-05	0.00013	CcSEcCtD
Diclofenac—Cardiac disorder—Methotrexate—psoriasis	1.61e-05	0.00013	CcSEcCtD
Diclofenac—Fatigue—Triamcinolone—psoriasis	1.61e-05	0.00013	CcSEcCtD
Diclofenac—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.6e-05	0.000129	CcSEcCtD
Diclofenac—Asthenia—Cyclosporine—psoriasis	1.6e-05	0.000129	CcSEcCtD
Diclofenac—Pain—Triamcinolone—psoriasis	1.59e-05	0.000129	CcSEcCtD
Diclofenac—Loss of consciousness—Prednisone—psoriasis	1.59e-05	0.000128	CcSEcCtD
Diclofenac—Hypotension—Betamethasone—psoriasis	1.58e-05	0.000128	CcSEcCtD
Diclofenac—Hypotension—Dexamethasone—psoriasis	1.58e-05	0.000128	CcSEcCtD
Diclofenac—Pruritus—Cyclosporine—psoriasis	1.58e-05	0.000127	CcSEcCtD
Diclofenac—Urticaria—Hydrocortisone—psoriasis	1.57e-05	0.000127	CcSEcCtD
Diclofenac—Angiopathy—Methotrexate—psoriasis	1.57e-05	0.000127	CcSEcCtD
Diclofenac—KCNQ2—Axon guidance—IL6—psoriasis	1.57e-05	0.000423	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—IL6—psoriasis	1.57e-05	0.000423	CbGpPWpGaD
Diclofenac—Immune system disorder—Methotrexate—psoriasis	1.57e-05	0.000127	CcSEcCtD
Diclofenac—Abdominal pain—Hydrocortisone—psoriasis	1.57e-05	0.000127	CcSEcCtD
Diclofenac—Body temperature increased—Hydrocortisone—psoriasis	1.57e-05	0.000127	CcSEcCtD
Diclofenac—Convulsion—Prednisone—psoriasis	1.56e-05	0.000126	CcSEcCtD
Diclofenac—Mediastinal disorder—Methotrexate—psoriasis	1.56e-05	0.000126	CcSEcCtD
Diclofenac—Asthenia—Mycophenolate mofetil—psoriasis	1.56e-05	0.000126	CcSEcCtD
Diclofenac—CXCR1—Signaling by GPCR—TYK2—psoriasis	1.56e-05	0.000421	CbGpPWpGaD
Diclofenac—Hypertension—Prednisone—psoriasis	1.56e-05	0.000126	CcSEcCtD
Diclofenac—Chills—Methotrexate—psoriasis	1.55e-05	0.000126	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Betamethasone—psoriasis	1.54e-05	0.000125	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.54e-05	0.000125	CcSEcCtD
Diclofenac—PTGS1—Metabolism—CYP2S1—psoriasis	1.54e-05	0.000415	CbGpPWpGaD
Diclofenac—Pruritus—Mycophenolate mofetil—psoriasis	1.54e-05	0.000124	CcSEcCtD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—IL6—psoriasis	1.54e-05	0.000415	CbGpPWpGaD
Diclofenac—Myalgia—Prednisone—psoriasis	1.54e-05	0.000124	CcSEcCtD
Diclofenac—Arthralgia—Prednisone—psoriasis	1.54e-05	0.000124	CcSEcCtD
Diclofenac—Feeling abnormal—Triamcinolone—psoriasis	1.54e-05	0.000124	CcSEcCtD
Diclofenac—Anxiety—Prednisone—psoriasis	1.53e-05	0.000124	CcSEcCtD
Diclofenac—Alopecia—Methotrexate—psoriasis	1.53e-05	0.000124	CcSEcCtD
Diclofenac—Insomnia—Dexamethasone—psoriasis	1.53e-05	0.000124	CcSEcCtD
Diclofenac—Insomnia—Betamethasone—psoriasis	1.53e-05	0.000124	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	1.53e-05	0.000123	CcSEcCtD
Diclofenac—Diarrhoea—Cyclosporine—psoriasis	1.52e-05	0.000123	CcSEcCtD
Diclofenac—Paraesthesia—Betamethasone—psoriasis	1.52e-05	0.000123	CcSEcCtD
Diclofenac—Paraesthesia—Dexamethasone—psoriasis	1.52e-05	0.000123	CcSEcCtD
Diclofenac—Discomfort—Prednisone—psoriasis	1.52e-05	0.000123	CcSEcCtD
Diclofenac—Mental disorder—Methotrexate—psoriasis	1.52e-05	0.000123	CcSEcCtD
Diclofenac—Erythema—Methotrexate—psoriasis	1.51e-05	0.000122	CcSEcCtD
Diclofenac—Malnutrition—Methotrexate—psoriasis	1.51e-05	0.000122	CcSEcCtD
Diclofenac—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	1.5e-05	0.000404	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—CXCL8—psoriasis	1.49e-05	0.000403	CbGpPWpGaD
Diclofenac—Hypersensitivity—Prednisolone—psoriasis	1.49e-05	0.000121	CcSEcCtD
Diclofenac—Dyspepsia—Betamethasone—psoriasis	1.49e-05	0.00012	CcSEcCtD
Diclofenac—Dyspepsia—Dexamethasone—psoriasis	1.49e-05	0.00012	CcSEcCtD
Diclofenac—Diarrhoea—Mycophenolate mofetil—psoriasis	1.49e-05	0.00012	CcSEcCtD
Diclofenac—Urticaria—Triamcinolone—psoriasis	1.48e-05	0.00012	CcSEcCtD
Diclofenac—Dysgeusia—Methotrexate—psoriasis	1.48e-05	0.000119	CcSEcCtD
Diclofenac—Body temperature increased—Triamcinolone—psoriasis	1.47e-05	0.000119	CcSEcCtD
Diclofenac—Dizziness—Cyclosporine—psoriasis	1.47e-05	0.000119	CcSEcCtD
Diclofenac—Oedema—Prednisone—psoriasis	1.47e-05	0.000119	CcSEcCtD
Diclofenac—Anaphylactic shock—Prednisone—psoriasis	1.47e-05	0.000119	CcSEcCtD
Diclofenac—Decreased appetite—Dexamethasone—psoriasis	1.47e-05	0.000119	CcSEcCtD
Diclofenac—Decreased appetite—Betamethasone—psoriasis	1.47e-05	0.000119	CcSEcCtD
Diclofenac—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.46e-05	0.000395	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.46e-05	0.000395	CbGpPWpGaD
Diclofenac—Infection—Prednisone—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Dexamethasone—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Betamethasone—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—CXCL8—Cellular responses to stress—VEGFA—psoriasis	1.46e-05	0.000394	CbGpPWpGaD
Diclofenac—Back pain—Methotrexate—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—CXCL8—Cellular Senescence—TP53—psoriasis	1.46e-05	0.000394	CbGpPWpGaD
Diclofenac—Hypersensitivity—Hydrocortisone—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—Fatigue—Dexamethasone—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—Fatigue—Betamethasone—psoriasis	1.46e-05	0.000118	CcSEcCtD
Diclofenac—PLA2G2A—Metabolism—CAT—psoriasis	1.45e-05	0.000392	CbGpPWpGaD
Diclofenac—Shock—Prednisone—psoriasis	1.45e-05	0.000117	CcSEcCtD
Diclofenac—Pain—Betamethasone—psoriasis	1.45e-05	0.000117	CcSEcCtD
Diclofenac—Pain—Dexamethasone—psoriasis	1.45e-05	0.000117	CcSEcCtD
Diclofenac—CXCL8—Cellular responses to stress—STAT3—psoriasis	1.44e-05	0.00039	CbGpPWpGaD
Diclofenac—Nervous system disorder—Prednisone—psoriasis	1.44e-05	0.000117	CcSEcCtD
Diclofenac—PTGS2—Metabolism—NDUFA5—psoriasis	1.44e-05	0.000388	CbGpPWpGaD
Diclofenac—Tachycardia—Prednisone—psoriasis	1.44e-05	0.000116	CcSEcCtD
Diclofenac—Dizziness—Mycophenolate mofetil—psoriasis	1.44e-05	0.000116	CcSEcCtD
Diclofenac—Skin disorder—Prednisone—psoriasis	1.43e-05	0.000116	CcSEcCtD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.43e-05	0.000386	CbGpPWpGaD
Diclofenac—Hyperhidrosis—Prednisone—psoriasis	1.42e-05	0.000115	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—psoriasis	1.42e-05	0.000115	CcSEcCtD
Diclofenac—Asthenia—Hydrocortisone—psoriasis	1.42e-05	0.000115	CcSEcCtD
Diclofenac—Vomiting—Cyclosporine—psoriasis	1.42e-05	0.000115	CcSEcCtD
Diclofenac—Rash—Cyclosporine—psoriasis	1.4e-05	0.000114	CcSEcCtD
Diclofenac—Anorexia—Prednisone—psoriasis	1.4e-05	0.000114	CcSEcCtD
Diclofenac—Dermatitis—Cyclosporine—psoriasis	1.4e-05	0.000113	CcSEcCtD
Diclofenac—Pruritus—Hydrocortisone—psoriasis	1.4e-05	0.000113	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—psoriasis	1.4e-05	0.000113	CcSEcCtD
Diclofenac—Headache—Cyclosporine—psoriasis	1.4e-05	0.000113	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—psoriasis	1.39e-05	0.000113	CcSEcCtD
Diclofenac—Feeling abnormal—Dexamethasone—psoriasis	1.39e-05	0.000113	CcSEcCtD
Diclofenac—Feeling abnormal—Betamethasone—psoriasis	1.39e-05	0.000113	CcSEcCtD
Diclofenac—KCNQ2—Developmental Biology—TNF—psoriasis	1.39e-05	0.000374	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—TNF—psoriasis	1.39e-05	0.000374	CbGpPWpGaD
Diclofenac—Gastrointestinal pain—Betamethasone—psoriasis	1.38e-05	0.000112	CcSEcCtD
Diclofenac—Gastrointestinal pain—Dexamethasone—psoriasis	1.38e-05	0.000112	CcSEcCtD
Diclofenac—CYP2B6—Metabolism—NDUFA5—psoriasis	1.38e-05	0.000373	CbGpPWpGaD
Diclofenac—Vomiting—Mycophenolate mofetil—psoriasis	1.38e-05	0.000112	CcSEcCtD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.37e-05	0.000371	CbGpPWpGaD
Diclofenac—Hypersensitivity—Triamcinolone—psoriasis	1.37e-05	0.000111	CcSEcCtD
Diclofenac—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.37e-05	0.00037	CbGpPWpGaD
Diclofenac—Rash—Mycophenolate mofetil—psoriasis	1.37e-05	0.000111	CcSEcCtD
Diclofenac—Dermatitis—Mycophenolate mofetil—psoriasis	1.37e-05	0.000111	CcSEcCtD
Diclofenac—Headache—Mycophenolate mofetil—psoriasis	1.36e-05	0.00011	CcSEcCtD
Diclofenac—Malaise—Methotrexate—psoriasis	1.36e-05	0.00011	CcSEcCtD
Diclofenac—CXCR1—Signaling by GPCR—CXCL8—psoriasis	1.36e-05	0.000366	CbGpPWpGaD
Diclofenac—Vertigo—Methotrexate—psoriasis	1.36e-05	0.00011	CcSEcCtD
Diclofenac—Diarrhoea—Hydrocortisone—psoriasis	1.35e-05	0.00011	CcSEcCtD
Diclofenac—CYP2E1—Metabolism—NDUFA5—psoriasis	1.35e-05	0.000365	CbGpPWpGaD
Diclofenac—Leukopenia—Methotrexate—psoriasis	1.35e-05	0.000109	CcSEcCtD
Diclofenac—SCN4A—Developmental Biology—NFKB1—psoriasis	1.35e-05	0.000364	CbGpPWpGaD
Diclofenac—ALB—Platelet degranulation—VEGFA—psoriasis	1.34e-05	0.000363	CbGpPWpGaD
Diclofenac—Urticaria—Dexamethasone—psoriasis	1.34e-05	0.000109	CcSEcCtD
Diclofenac—Urticaria—Betamethasone—psoriasis	1.34e-05	0.000109	CcSEcCtD
Diclofenac—ALB—Folate Metabolism—TNF—psoriasis	1.34e-05	0.000362	CbGpPWpGaD
Diclofenac—Musculoskeletal discomfort—Prednisone—psoriasis	1.34e-05	0.000109	CcSEcCtD
Diclofenac—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.34e-05	0.000362	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.34e-05	0.000362	CbGpPWpGaD
Diclofenac—Dizziness—Prednisolone—psoriasis	1.34e-05	0.000108	CcSEcCtD
Diclofenac—CXCL8—Signaling Pathways—CCL20—psoriasis	1.34e-05	0.000362	CbGpPWpGaD
Diclofenac—Asthenia—Triamcinolone—psoriasis	1.34e-05	0.000108	CcSEcCtD
Diclofenac—Body temperature increased—Betamethasone—psoriasis	1.34e-05	0.000108	CcSEcCtD
Diclofenac—Abdominal pain—Betamethasone—psoriasis	1.34e-05	0.000108	CcSEcCtD
Diclofenac—Body temperature increased—Dexamethasone—psoriasis	1.34e-05	0.000108	CcSEcCtD
Diclofenac—Abdominal pain—Dexamethasone—psoriasis	1.34e-05	0.000108	CcSEcCtD
Diclofenac—CXCL8—Cellular Senescence—IL6—psoriasis	1.34e-05	0.00036	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.33e-05	0.00036	CbGpPWpGaD
Diclofenac—Insomnia—Prednisone—psoriasis	1.33e-05	0.000108	CcSEcCtD
Diclofenac—Nausea—Cyclosporine—psoriasis	1.32e-05	0.000107	CcSEcCtD
Diclofenac—Paraesthesia—Prednisone—psoriasis	1.32e-05	0.000107	CcSEcCtD
Diclofenac—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.32e-05	0.000356	CbGpPWpGaD
Diclofenac—Pruritus—Triamcinolone—psoriasis	1.32e-05	0.000107	CcSEcCtD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.32e-05	0.000355	CbGpPWpGaD
Diclofenac—Cough—Methotrexate—psoriasis	1.32e-05	0.000106	CcSEcCtD
Diclofenac—Dizziness—Hydrocortisone—psoriasis	1.31e-05	0.000106	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—psoriasis	1.31e-05	0.000106	CcSEcCtD
Diclofenac—Dyspepsia—Prednisone—psoriasis	1.3e-05	0.000105	CcSEcCtD
Diclofenac—ALB—Hemostasis—ITGAL—psoriasis	1.29e-05	0.000349	CbGpPWpGaD
Diclofenac—Nausea—Mycophenolate mofetil—psoriasis	1.29e-05	0.000104	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—psoriasis	1.28e-05	0.000104	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—psoriasis	1.28e-05	0.000104	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—psoriasis	1.28e-05	0.000104	CcSEcCtD
Diclofenac—Decreased appetite—Prednisone—psoriasis	1.28e-05	0.000104	CcSEcCtD
Diclofenac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.28e-05	0.000345	CbGpPWpGaD
Diclofenac—Rash—Prednisolone—psoriasis	1.28e-05	0.000103	CcSEcCtD
Diclofenac—Dermatitis—Prednisolone—psoriasis	1.28e-05	0.000103	CcSEcCtD
Diclofenac—CYP1A1—Metabolism—NDUFA5—psoriasis	1.28e-05	0.000344	CbGpPWpGaD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	1.28e-05	0.000103	CcSEcCtD
Diclofenac—Fatigue—Prednisone—psoriasis	1.27e-05	0.000103	CcSEcCtD
Diclofenac—Headache—Prednisolone—psoriasis	1.27e-05	0.000103	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—psoriasis	1.27e-05	0.000103	CcSEcCtD
Diclofenac—CXCL8—Metabolism of proteins—LEP—psoriasis	1.26e-05	0.000341	CbGpPWpGaD
Diclofenac—Constipation—Prednisone—psoriasis	1.26e-05	0.000102	CcSEcCtD
Diclofenac—Vomiting—Hydrocortisone—psoriasis	1.26e-05	0.000102	CcSEcCtD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.25e-05	0.000338	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.25e-05	0.000338	CbGpPWpGaD
Diclofenac—Rash—Hydrocortisone—psoriasis	1.25e-05	0.000101	CcSEcCtD
Diclofenac—Dermatitis—Hydrocortisone—psoriasis	1.25e-05	0.000101	CcSEcCtD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.24e-05	0.000336	CbGpPWpGaD
Diclofenac—TTR—Disease—HLA-A—psoriasis	1.24e-05	0.000335	CbGpPWpGaD
Diclofenac—Confusional state—Methotrexate—psoriasis	1.24e-05	0.0001	CcSEcCtD
Diclofenac—Headache—Hydrocortisone—psoriasis	1.24e-05	0.0001	CcSEcCtD
Diclofenac—Dizziness—Triamcinolone—psoriasis	1.23e-05	9.97e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—psoriasis	1.23e-05	9.96e-05	CcSEcCtD
Diclofenac—SCN4A—Developmental Biology—VEGFA—psoriasis	1.23e-05	0.000331	CbGpPWpGaD
Diclofenac—Infection—Methotrexate—psoriasis	1.22e-05	9.89e-05	CcSEcCtD
Diclofenac—PTGS2—Metabolism—CYP2S1—psoriasis	1.22e-05	0.00033	CbGpPWpGaD
Diclofenac—Feeling abnormal—Prednisone—psoriasis	1.21e-05	9.82e-05	CcSEcCtD
Diclofenac—Asthenia—Betamethasone—psoriasis	1.21e-05	9.81e-05	CcSEcCtD
Diclofenac—Asthenia—Dexamethasone—psoriasis	1.21e-05	9.81e-05	CcSEcCtD
Diclofenac—SCN4A—Developmental Biology—STAT3—psoriasis	1.21e-05	0.000327	CbGpPWpGaD
Diclofenac—Nervous system disorder—Methotrexate—psoriasis	1.21e-05	9.76e-05	CcSEcCtD
Diclofenac—CXCR1—Signaling Pathways—APOE—psoriasis	1.21e-05	0.000326	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—LEP—psoriasis	1.21e-05	0.000326	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.21e-05	0.000325	CbGpPWpGaD
Diclofenac—Thrombocytopenia—Methotrexate—psoriasis	1.21e-05	9.75e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Prednisone—psoriasis	1.2e-05	9.74e-05	CcSEcCtD
Diclofenac—Nausea—Prednisolone—psoriasis	1.2e-05	9.74e-05	CcSEcCtD
Diclofenac—Pruritus—Dexamethasone—psoriasis	1.2e-05	9.68e-05	CcSEcCtD
Diclofenac—Pruritus—Betamethasone—psoriasis	1.2e-05	9.68e-05	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—psoriasis	1.2e-05	9.67e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—psoriasis	1.19e-05	9.62e-05	CcSEcCtD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.19e-05	0.000321	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.19e-05	0.000321	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—IL6—psoriasis	1.19e-05	0.00032	CbGpPWpGaD
Diclofenac—Vomiting—Triamcinolone—psoriasis	1.19e-05	9.59e-05	CcSEcCtD
Diclofenac—ALB—Folate Metabolism—TP53—psoriasis	1.18e-05	0.00032	CbGpPWpGaD
Diclofenac—Nausea—Hydrocortisone—psoriasis	1.18e-05	9.51e-05	CcSEcCtD
Diclofenac—Rash—Triamcinolone—psoriasis	1.18e-05	9.51e-05	CcSEcCtD
Diclofenac—CYP2B6—Metabolism—CYP2S1—psoriasis	1.17e-05	0.000317	CbGpPWpGaD
Diclofenac—Dermatitis—Triamcinolone—psoriasis	1.17e-05	9.5e-05	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—psoriasis	1.17e-05	9.49e-05	CcSEcCtD
Diclofenac—ABCC4—Hemostasis—NOS2—psoriasis	1.17e-05	0.000316	CbGpPWpGaD
Diclofenac—Urticaria—Prednisone—psoriasis	1.17e-05	9.46e-05	CcSEcCtD
Diclofenac—CYP2C8—Metabolism—NDUFA5—psoriasis	1.17e-05	0.000316	CbGpPWpGaD
Diclofenac—Headache—Triamcinolone—psoriasis	1.17e-05	9.44e-05	CcSEcCtD
Diclofenac—CYP2C18—Metabolism—CARM1—psoriasis	1.17e-05	0.000315	CbGpPWpGaD
Diclofenac—Abdominal pain—Prednisone—psoriasis	1.16e-05	9.42e-05	CcSEcCtD
Diclofenac—Body temperature increased—Prednisone—psoriasis	1.16e-05	9.42e-05	CcSEcCtD
Diclofenac—ALB—Metabolism—NDUFA5—psoriasis	1.16e-05	0.000314	CbGpPWpGaD
Diclofenac—TTR—Disease—APOE—psoriasis	1.16e-05	0.000313	CbGpPWpGaD
Diclofenac—Diarrhoea—Dexamethasone—psoriasis	1.16e-05	9.36e-05	CcSEcCtD
Diclofenac—Diarrhoea—Betamethasone—psoriasis	1.16e-05	9.36e-05	CcSEcCtD
Diclofenac—CYP2E1—Metabolism—CYP2S1—psoriasis	1.15e-05	0.00031	CbGpPWpGaD
Diclofenac—Hypotension—Methotrexate—psoriasis	1.15e-05	9.3e-05	CcSEcCtD
Diclofenac—UGT2B7—Metabolism—CARM1—psoriasis	1.14e-05	0.000306	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—APOE—psoriasis	1.13e-05	0.000305	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NFKBIA—psoriasis	1.12e-05	0.000303	CbGpPWpGaD
Diclofenac—Musculoskeletal discomfort—Methotrexate—psoriasis	1.12e-05	9.07e-05	CcSEcCtD
Diclofenac—Dizziness—Betamethasone—psoriasis	1.12e-05	9.05e-05	CcSEcCtD
Diclofenac—Dizziness—Dexamethasone—psoriasis	1.12e-05	9.05e-05	CcSEcCtD
Diclofenac—KCNQ2—Developmental Biology—IL6—psoriasis	1.12e-05	0.000302	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—IL6—psoriasis	1.12e-05	0.000302	CbGpPWpGaD
Diclofenac—Insomnia—Methotrexate—psoriasis	1.11e-05	9e-05	CcSEcCtD
Diclofenac—Nausea—Triamcinolone—psoriasis	1.11e-05	8.95e-05	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—psoriasis	1.11e-05	8.94e-05	CcSEcCtD
Diclofenac—CXCL8—Cellular responses to stress—TP53—psoriasis	1.1e-05	0.000297	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SOCS1—psoriasis	1.1e-05	0.000297	CbGpPWpGaD
Diclofenac—Dyspnoea—Methotrexate—psoriasis	1.1e-05	8.88e-05	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—psoriasis	1.09e-05	8.85e-05	CcSEcCtD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.09e-05	0.000294	CbGpPWpGaD
Diclofenac—Hypersensitivity—Prednisone—psoriasis	1.09e-05	8.78e-05	CcSEcCtD
Diclofenac—CYP1A1—Metabolism—CYP2S1—psoriasis	1.08e-05	0.000293	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.08e-05	0.000293	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—IL6—psoriasis	1.08e-05	0.000293	CbGpPWpGaD
Diclofenac—Dyspepsia—Methotrexate—psoriasis	1.08e-05	8.76e-05	CcSEcCtD
Diclofenac—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.08e-05	0.000292	CbGpPWpGaD
Diclofenac—TTR—Disease—NOS2—psoriasis	1.08e-05	0.000292	CbGpPWpGaD
Diclofenac—Vomiting—Betamethasone—psoriasis	1.08e-05	8.7e-05	CcSEcCtD
Diclofenac—Vomiting—Dexamethasone—psoriasis	1.08e-05	8.7e-05	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—psoriasis	1.07e-05	8.65e-05	CcSEcCtD
Diclofenac—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.07e-05	0.000288	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CAT—psoriasis	1.07e-05	0.000288	CbGpPWpGaD
Diclofenac—Rash—Betamethasone—psoriasis	1.07e-05	8.62e-05	CcSEcCtD
Diclofenac—Rash—Dexamethasone—psoriasis	1.07e-05	8.62e-05	CcSEcCtD
Diclofenac—Dermatitis—Betamethasone—psoriasis	1.07e-05	8.62e-05	CcSEcCtD
Diclofenac—Dermatitis—Dexamethasone—psoriasis	1.07e-05	8.62e-05	CcSEcCtD
Diclofenac—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	1.06e-05	0.000287	CbGpPWpGaD
Diclofenac—Gastrointestinal disorder—Methotrexate—psoriasis	1.06e-05	8.6e-05	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—psoriasis	1.06e-05	8.58e-05	CcSEcCtD
Diclofenac—Headache—Dexamethasone—psoriasis	1.06e-05	8.57e-05	CcSEcCtD
Diclofenac—Headache—Betamethasone—psoriasis	1.06e-05	8.57e-05	CcSEcCtD
Diclofenac—Asthenia—Prednisone—psoriasis	1.06e-05	8.55e-05	CcSEcCtD
Diclofenac—Pain—Methotrexate—psoriasis	1.05e-05	8.51e-05	CcSEcCtD
Diclofenac—SCN4A—Developmental Biology—TNF—psoriasis	1.05e-05	0.000283	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NDUFA5—psoriasis	1.04e-05	0.000282	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TNF—psoriasis	1.04e-05	0.000281	CbGpPWpGaD
Diclofenac—Pruritus—Prednisone—psoriasis	1.04e-05	8.43e-05	CcSEcCtD
Diclofenac—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.03e-05	0.000278	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TNF—psoriasis	1.02e-05	0.000275	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NDUFA5—psoriasis	1.02e-05	0.000275	CbGpPWpGaD
Diclofenac—Feeling abnormal—Methotrexate—psoriasis	1.01e-05	8.2e-05	CcSEcCtD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.01e-05	0.000273	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—IL6—psoriasis	1.01e-05	0.000272	CbGpPWpGaD
Diclofenac—Diarrhoea—Prednisone—psoriasis	1.01e-05	8.15e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—psoriasis	1.01e-05	8.14e-05	CcSEcCtD
Diclofenac—Nausea—Betamethasone—psoriasis	1e-05	8.13e-05	CcSEcCtD
Diclofenac—Nausea—Dexamethasone—psoriasis	1e-05	8.13e-05	CcSEcCtD
Diclofenac—CYP2C8—Metabolism—CYP2S1—psoriasis	9.95e-06	0.000268	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP2S1—psoriasis	9.89e-06	0.000267	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PPARG—psoriasis	9.84e-06	0.000265	CbGpPWpGaD
Diclofenac—Urticaria—Methotrexate—psoriasis	9.78e-06	7.91e-05	CcSEcCtD
Diclofenac—Dizziness—Prednisone—psoriasis	9.74e-06	7.88e-05	CcSEcCtD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.74e-06	0.000263	CbGpPWpGaD
Diclofenac—Body temperature increased—Methotrexate—psoriasis	9.73e-06	7.87e-05	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—psoriasis	9.73e-06	7.87e-05	CcSEcCtD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.55e-06	0.000258	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NDUFA5—psoriasis	9.52e-06	0.000257	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.48e-06	0.000256	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	9.47e-06	0.000256	CbGpPWpGaD
Diclofenac—Vomiting—Prednisone—psoriasis	9.37e-06	7.57e-05	CcSEcCtD
Diclofenac—Rash—Prednisone—psoriasis	9.29e-06	7.51e-05	CcSEcCtD
Diclofenac—Dermatitis—Prednisone—psoriasis	9.28e-06	7.5e-05	CcSEcCtD
Diclofenac—Headache—Prednisone—psoriasis	9.23e-06	7.46e-05	CcSEcCtD
Diclofenac—UGT1A1—Metabolism—CARM1—psoriasis	9.23e-06	0.000249	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TYK2—psoriasis	9.21e-06	0.000248	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—psoriasis	9.2e-06	0.000248	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	9.12e-06	0.000246	CbGpPWpGaD
Diclofenac—Hypersensitivity—Methotrexate—psoriasis	9.07e-06	7.34e-05	CcSEcCtD
Diclofenac—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	9.04e-06	0.000244	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CARM1—psoriasis	8.9e-06	0.00024	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP2S1—psoriasis	8.88e-06	0.00024	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.88e-06	0.00024	CbGpPWpGaD
Diclofenac—TTR—Disease—TYK2—psoriasis	8.85e-06	0.000239	CbGpPWpGaD
Diclofenac—Asthenia—Methotrexate—psoriasis	8.83e-06	7.14e-05	CcSEcCtD
Diclofenac—Nausea—Prednisone—psoriasis	8.75e-06	7.08e-05	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—psoriasis	8.71e-06	7.04e-05	CcSEcCtD
Diclofenac—ABCB1—Metabolism—CYP2S1—psoriasis	8.67e-06	0.000234	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—IL6—psoriasis	8.61e-06	0.000232	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—IL6—psoriasis	8.47e-06	0.000229	CbGpPWpGaD
Diclofenac—Diarrhoea—Methotrexate—psoriasis	8.42e-06	6.81e-05	CcSEcCtD
Diclofenac—PTGS2—Spinal Cord Injury—IL6—psoriasis	8.42e-06	0.000227	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.31e-06	0.000224	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—APOE—psoriasis	8.29e-06	0.000224	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.28e-06	0.000223	CbGpPWpGaD
Diclofenac—Dizziness—Methotrexate—psoriasis	8.14e-06	6.58e-05	CcSEcCtD
Diclofenac—CYP1A2—Metabolism—NDUFA5—psoriasis	8.14e-06	0.00022	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—APOE—psoriasis	8.12e-06	0.000219	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—LEP—psoriasis	8.12e-06	0.000219	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP2S1—psoriasis	8.1e-06	0.000218	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.07e-06	0.000218	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CXCL8—psoriasis	8.02e-06	0.000216	CbGpPWpGaD
Diclofenac—TTR—Disease—CD4—psoriasis	8e-06	0.000216	CbGpPWpGaD
Diclofenac—Vomiting—Methotrexate—psoriasis	7.83e-06	6.33e-05	CcSEcCtD
Diclofenac—Rash—Methotrexate—psoriasis	7.76e-06	6.28e-05	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—psoriasis	7.76e-06	6.27e-05	CcSEcCtD
Diclofenac—Headache—Methotrexate—psoriasis	7.71e-06	6.24e-05	CcSEcCtD
Diclofenac—CXCR1—Signaling by GPCR—IL6—psoriasis	7.63e-06	0.000206	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.59e-06	0.000205	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NFKBIA—psoriasis	7.57e-06	0.000204	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CARM1—psoriasis	7.52e-06	0.000203	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—JUN—psoriasis	7.46e-06	0.000201	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SOCS1—psoriasis	7.38e-06	0.000199	CbGpPWpGaD
Diclofenac—Nausea—Methotrexate—psoriasis	7.31e-06	5.91e-05	CcSEcCtD
Diclofenac—ALOX5—Metabolism—PPARG—psoriasis	7.22e-06	0.000195	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CAT—psoriasis	7.18e-06	0.000194	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NFKB1—psoriasis	7.18e-06	0.000194	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.1e-06	0.000191	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—TYK2—psoriasis	7.04e-06	0.00019	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.03e-06	0.00019	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CAT—psoriasis	6.98e-06	0.000188	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP2S1—psoriasis	6.92e-06	0.000187	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—VEGFA—psoriasis	6.79e-06	0.000183	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.72e-06	0.000181	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—VEGFA—psoriasis	6.51e-06	0.000176	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	6.47e-06	0.000175	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—STAT3—psoriasis	6.45e-06	0.000174	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.41e-06	0.000173	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NDUFA5—psoriasis	6.28e-06	0.000169	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.26e-06	0.000169	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TYK2—psoriasis	6.2e-06	0.000167	CbGpPWpGaD
Diclofenac—TTR—Disease—STAT3—psoriasis	6.2e-06	0.000167	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CARM1—psoriasis	5.97e-06	0.000161	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	5.96e-06	0.000161	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.87e-06	0.000158	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CARM1—psoriasis	5.74e-06	0.000155	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.69e-06	0.000153	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CAT—psoriasis	5.67e-06	0.000153	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CARM1—psoriasis	5.62e-06	0.000152	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.58e-06	0.000151	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—APOE—psoriasis	5.58e-06	0.00015	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CAT—psoriasis	5.47e-06	0.000148	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—APOE—psoriasis	5.45e-06	0.000147	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—LEP—psoriasis	5.45e-06	0.000147	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HLA-A—psoriasis	5.44e-06	0.000147	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—APOE—psoriasis	5.43e-06	0.000146	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CXCL8—psoriasis	5.4e-06	0.000146	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2S1—psoriasis	5.34e-06	0.000144	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NOS2—psoriasis	5.31e-06	0.000143	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CARM1—psoriasis	5.3e-06	0.000143	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.21e-06	0.000141	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.18e-06	0.00014	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—psoriasis	5.13e-06	0.000138	CbGpPWpGaD
Diclofenac—ABCC1—Disease—APOE—psoriasis	5.08e-06	0.000137	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NFKBIA—psoriasis	5.08e-06	0.000137	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.03e-06	0.000136	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—JUN—psoriasis	5.02e-06	0.000135	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.95e-06	0.000134	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—psoriasis	4.92e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PPARG—psoriasis	4.86e-06	0.000131	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CARM1—psoriasis	4.86e-06	0.000131	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CARM1—psoriasis	4.83e-06	0.00013	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NFKB1—psoriasis	4.83e-06	0.00013	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOS2—psoriasis	4.73e-06	0.000128	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PPARG—psoriasis	4.73e-06	0.000128	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.65e-06	0.000126	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CAT—psoriasis	4.63e-06	0.000125	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.54e-06	0.000123	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.51e-06	0.000122	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL6—psoriasis	4.5e-06	0.000122	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.44e-06	0.00012	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—APOE—psoriasis	4.41e-06	0.000119	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—psoriasis	4.38e-06	0.000118	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—STAT3—psoriasis	4.34e-06	0.000117	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CARM1—psoriasis	4.34e-06	0.000117	CbGpPWpGaD
Diclofenac—TTR—Disease—IL6—psoriasis	4.33e-06	0.000117	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—APOE—psoriasis	4.25e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.24e-06	0.000114	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CARM1—psoriasis	4.23e-06	0.000114	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TYK2—psoriasis	4.16e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.05e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CARM1—psoriasis	3.95e-06	0.000107	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TYK2—psoriasis	3.87e-06	0.000105	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PPARG—psoriasis	3.84e-06	0.000104	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PPARG—psoriasis	3.7e-06	9.99e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.7e-06	9.97e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CAT—psoriasis	3.67e-06	9.91e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HLA-A—psoriasis	3.65e-06	9.85e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.63e-06	9.78e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—APOE—psoriasis	3.59e-06	9.7e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CAT—psoriasis	3.53e-06	9.52e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CD4—psoriasis	3.5e-06	9.45e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CAT—psoriasis	3.46e-06	9.33e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—psoriasis	3.44e-06	9.29e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APOE—psoriasis	3.41e-06	9.19e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CARM1—psoriasis	3.38e-06	9.12e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—JUN—psoriasis	3.36e-06	9.08e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—psoriasis	3.31e-06	8.93e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAT—psoriasis	3.26e-06	8.79e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NFKB1—psoriasis	3.24e-06	8.74e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS2—psoriasis	3.17e-06	8.57e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.16e-06	8.52e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—psoriasis	3.13e-06	8.45e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—psoriasis	3.07e-06	8.29e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—psoriasis	3.03e-06	8.18e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAT—psoriasis	2.99e-06	8.06e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAT—psoriasis	2.97e-06	8.02e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—psoriasis	2.94e-06	7.93e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—psoriasis	2.91e-06	7.85e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APOE—psoriasis	2.85e-06	7.7e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APOE—psoriasis	2.74e-06	7.4e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—psoriasis	2.71e-06	7.32e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOE—psoriasis	2.69e-06	7.25e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAT—psoriasis	2.67e-06	7.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CARM1—psoriasis	2.61e-06	7.03e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAT—psoriasis	2.6e-06	7.02e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TYK2—psoriasis	2.6e-06	7.02e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOE—psoriasis	2.53e-06	6.83e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—psoriasis	2.49e-06	6.71e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAT—psoriasis	2.43e-06	6.56e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—psoriasis	2.39e-06	6.44e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—psoriasis	2.35e-06	6.34e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—psoriasis	2.34e-06	6.31e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—psoriasis	2.32e-06	6.26e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOE—psoriasis	2.32e-06	6.26e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOE—psoriasis	2.31e-06	6.23e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—psoriasis	2.22e-06	5.99e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—psoriasis	2.21e-06	5.95e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAT—psoriasis	2.08e-06	5.61e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOE—psoriasis	2.07e-06	5.59e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—psoriasis	2.03e-06	5.49e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOE—psoriasis	2.02e-06	5.46e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—psoriasis	2.02e-06	5.46e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—psoriasis	2.01e-06	5.42e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—psoriasis	1.89e-06	5.11e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOE—psoriasis	1.89e-06	5.1e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—psoriasis	1.82e-06	4.91e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—psoriasis	1.8e-06	4.87e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—psoriasis	1.76e-06	4.75e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—psoriasis	1.65e-06	4.44e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOE—psoriasis	1.61e-06	4.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAT—psoriasis	1.6e-06	4.33e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—psoriasis	1.41e-06	3.79e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—psoriasis	1.27e-06	3.43e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOE—psoriasis	1.25e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—psoriasis	1.09e-06	2.93e-05	CbGpPWpGaD
